Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionCovenant Asset Management, LLC
Latest Disclosed Ownership3,394 shares
Latest Disclosed Value $ 1,194,179
Covenant Asset Management, LLC reports 0.15% decrease in ownership of AMGN / Amgen Inc.

On April 14, 2026 - Covenant Asset Management, LLC filed a 13F-HR form disclosing ownership of 3,394 shares of Amgen Inc. (CH:AMGN) valued at $1,194,179 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 3,399 shares of Amgen Inc.. This represents a change in shares of -0.15% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-14 2026-03-31 13F AMGEN COM 031162100 3,394 -5 -0.15 1,194 7.37 0.1798
2026-01-30 2025-12-31 13F AMGEN COM 031162100 3,399 -2 -0.06 1,113 15.95 0.1318
2025-10-30 2025-09-30 13F AMGEN COM 031162100 3,401 -138 -3.90 960 -2.94 0.1085
2025-07-17 2025-06-30 13F AMGEN COM 031162100 3,539 -420 -10.61 988 -19.87 0.1460
2025-05-05 2025-03-31 13F AMGEN COM 031162100 3,959 -580 -12.78 1,233 4.23 0.2716
2025-01-30 2024-12-31 13F AMGEN COM 031162100 4,539 -716 -13.63 1,183 -30.12 0.1816
2024-11-12 2024-09-30 13F AMGEN COM 031162100 5,255 -206 -3.77 1,693 -0.76 0.2662
2024-08-02 2024-06-30 13F AMGEN COM 031162100 5,461 449 8.96 1,706 19.72 0.2714
2024-04-23 2024-03-31 13F AMGEN COM 031162100 5,012 259 5.45 1,425 4.17 0.2337
2024-01-22 2023-12-31 13F AMGEN COM 031162100 4,753 -205 -4.13 1,369 2.70 0.2459
2023-10-31 2023-09-30 13F AMGEN COM 031162100 4,958 31 0.63 1,333 21.87 0.3513
2023-07-12 2023-06-30 13F AMGEN COM 031162100 4,927 40 0.82 1,094 -7.45 0.2775
2023-04-27 2023-03-31 13F AMGEN COM 031162100 4,887 236 5.07 1,181 -3.28 0.2811
2023-01-24 2022-12-31 13F AMGEN COM 031162100 4,651 -40 -0.85 1,222 15.52 0.2916
2022-11-03 2022-09-30 13F AMGEN COM 031162100 4,691 -93 -1.94 1,057 -9.19 0.3014
2022-07-21 2022-06-30 13F AMGEN COM 031162100 4,784 61 1.29 1,164 1.93 0.3697
2022-04-29 2022-03-31 13F AMGEN COM 031162100 4,723 0 0.00 1,142 7.43 0.3085
2022-01-26 2021-12-31 13F AMGEN COM 031162100 4,723 47 1.01 1,063 6.94 0.2825
2021-10-27 2021-09-30 13F/A-1 AMGEN COM 031162100 4,676 -36 -0.76 994 -13.49 0.2951
2021-10-15 2021-09-30 13F AMGEN COM 031162100 4,676 -36 994 0.2963
2021-07-21 2021-06-30 13F AMGEN COM 031162100 4,712 0 0.00 1,149 -1.96 0.3419
2021-04-19 2021-03-31 13F AMGEN COM 031162100 4,712 128 2.79 1,172 11.20 0.3654
2021-01-28 2020-12-31 13F AMGEN COM 031162100 4,584 466 11.32 1,054 0.67 0.3473
2020-10-29 2020-09-30 13F AMGEN COM 031162100 4,118 -325 -7.31 1,047 -0.10 0.3355
2020-07-24 2020-06-30 13F AMGEN COM 031162100 4,443 1,351 43.69 1,048 67.15 0.2319
2020-04-22 2020-03-31 13F AMGEN COM 031162100 3,092 526 20.50 627 1.29 0.1891
2020-01-24 2019-12-31 13F AMGEN COM 031162100 2,566 -112 -4.18 619 19.50 0.2709
2019-10-18 2019-09-30 13F AMGEN COM 031162100 2,678 82 3.16 518 8.37 0.2601
2019-07-17 2019-06-30 13F AMGEN COM 031162100 2,596 115 4.64 478 1.49 0.2479
2019-04-26 2019-03-31 13F AMGEN COM 031162100 2,481 -215 -7.97 471 -15.74 0.2475
2019-01-08 2018-12-31 13F AMGEN COM 031162100 2,696 0 0.00 559 0.00 0.2816
2018-10-09 2018-09-30 13F AMGEN COM 031162100 2,696 45 1.70 559 14.31 0.2816
2018-07-12 2018-06-30 13F AMGEN COM 031162100 2,651 32 1.22 489 9.64 0.2642
2018-05-04 2018-03-31 13F AMGEN COM 031162100 2,619 395 17.76 446 15.25 0.2577
2018-01-12 2017-12-31 13F AMGEN COM 031162100 2,224 341 18.11 387 10.26 0.2250
2017-10-19 2017-09-30 13F AMGEN COM 031162100 1,883 0 0.00 351 8.33 0.2141
2017-07-11 2017-06-30 13F AMGEN COM 031162100 1,883 273 16.96 324 22.73 0.2074
2017-04-21 2017-03-31 13F AMGEN COM 031162100 1,610 -957 -37.28 264 -29.60 0.1780
2017-02-13 2016-12-31 13F AMGEN COM 031162100 2,567 2,567 375 0.2516
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.